InvestSMART

Lucozade, Ribena sale

British pharmaceuticals company GlaxoSmithKline is to sell brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).
By · 26 Apr 2013
By ·
26 Apr 2013
comments Comments
Upsell Banner
British pharmaceuticals company GlaxoSmithKline is to sell brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).
Share this article and show your support
Free Membership
Free Membership
InvestSMART
InvestSMART
Keep on reading more articles from InvestSMART. See more articles
Join the conversation
Join the conversation...
There are comments posted so far. Join the conversation, please login or Sign up.